Swamp Club Raises $7.0M Seed Round

First Tracks Biotherapeutics

First Tracks Biotherapeutics is a clinical stage biotechnology company advancing antibody therapies that modulate immune pathways implicated in autoimmune and inflammatory diseases. Its pipeline includes ANB033, a CD122 antagonist in development for celiac disease and eosinophilic esophagitis; rosnilimab, a pathogenic T cell depleter in development for rheumatoid arthritis; and ANB101, a BDCA2 modulator.

TriMagnetix

TriMagnetix is developing a fundamentally new class of processors powered by nanomagnetic triangles pioneering logic-in-memory architectures that are ultra-low power, inherently radiation-hardened, and non-volatile by design. Our triangle-based computing units integrate logic and memory using directional magnetization, unlocking performance in edge, aerospace, IoT, and secure embedded applications where conventional silicon falls short. Unlike traditional semiconductors or MRAM focused players, TriMagnetix delivers geometry-enabled computation that scales efficiently and operates with nanosecond bursts with no sustained power required to preserve data or processor state. We’re building for the next era of distributed, energy-efficient, and resilient computation. 🔹 Ideal for edge AI, radiation-rich environments, and hardware-level security 🔹 Architected for zero-standby power and in-situ logic execution 🔹 Backed by patented nanomagnetic designs Join us as we rethink computing beyond CMOS.